Open Joint Stock Company «Ferein» is a pharmaceutical company that has been manufacturing medicines since 2008. The number of medicines produced by the company is 59.
Open Joint Stock Company «Ferein» is registered in the unified state register of legal entities and individual entrepreneurs in 2008. The owner of the property is the Republic of Belarus – 25%, PJSC “Bryntsalov-A”(Moscow, Russian Federation) – 75%.
The main producing share is made up by injectable medicines produced on a full cycle. Analysis of the dynamics of the development of the Belarusian pharmaceutical market indicates a constant growing need for medicines of Open Joint Stock Company «Ferein». Products of the company are known and in demand.
Сoncentrating on the development and production of modern high-quality medicines with improved characteristics that meet the requirements of effectiveness and safety, expanding the list and forms of products, Open Joint Stock Company «Ferein» aims at achieving the strategic objective of providing consumers with high-quality and safe medicines at available prices.
The implementation of the Quality Policy by the company is achieved with the established and formalized pharmaceutical quality assurance and management system. That system includes operation of all the factors for constant quality assurance and prevention of nonconformities, from input quality control of raw materials to control of releasing and selling finished products, which are primarily carried out by the quality assurance (QA) and quality control (QC) departments, as well as producing and engineering services of the company.
Upholding the policy of making efforts to the implement the Quality Policy, the company makes regular investments in the quality management system, improves technological process. Achieving a leading position in product quality is a priority strategic task for Open Joint Stock Company «Ferein».